Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec 18;31(1):77-87.
doi: 10.1515/revneuro-2019-0001.

Exosome-encapsulated microRNAs as promising biomarkers for Alzheimer's disease

Jian-Jiao Chen  1   2 , Guang Yang  3 , Qing-Qing Yan  4 , Jie Zhao  4   5 , Shao Li  4   5
Affiliations
Review

Exosome-encapsulated microRNAs as promising biomarkers for Alzheimer's disease

Jian-Jiao Chen et al. Rev Neurosci. .

Abstract

Alzheimer's disease (AD) is a chronic neurodegenerative disease that locks into long clinical latency and low curative ratio. Therefore, early diagnosis before the clinical phase is quite essential and may be effective for therapeutic prevention. Peripheral blood or cerebrospinal fluid biomarkers symbolizing functional neuronal impairment are gradually applied to diagnose AD in research studies. Exosomes have generated immense interest in the diagnosis field of neurodegenerative disorders after confirmation of their roles as mediators, delivering important proteins and microRNAs (miRNAs) in intercellular communication. Compelling research results reveal that miRNAs released from exosomes modulate expression and function of amyloid precursor proteins and tau proteins. These findings open up possibility that dysfunctional exosomal miRNAs may influence AD progression. In this review, we summarized the existing knowledge of exosomal miRNAs and their involvement in AD, emphasizing their potential to serve as diagnostic biomarkers during the preclinical phase of AD.

Keywords: Alzheimer’s disease; biomarkers; exosomes; microRNAs.

PubMed Disclaimer

References

    1. Aksoy-Aksel, A., Zampa, F., and Schratt, G. (2014). MicroRNAs and synaptic plasticity – a mutual relationship. Philos. Trans. R. Soc. Lond. B Biol. Sci. 369, 20130515.
    1. Alzheimer Association. (2016). Alzheimer’s disease facts and figures. Alzheimers Dement. 12, 459–509.
    1. Cai, M., Wang, Y.W., Xu, S.H., Qiao, S., Shu, Q.F., Du, J.Z., Li, Y.G., and Liu, X.L. (2018). Regulatory effects of the long noncoding RNA RP11543N12.1 and microRNA3243p axis on the neuronal apoptosis induced by the inflammatory reactions of microglia. Int. J. Mol. Med. 42, 1741–1755.
    1. Canter, R., Penney, J., and Tsai, L. (2016). The road to restoring neural circuits for the treatment of Alzheimer’s disease. Nature. 539, 187–196.
    1. Chen, J.J., Zhao, B., Zhao, J., and Li, S. (2017). Potential roles of exosomal microRNAs as diagnostic biomarkers and therapeutic application in Alzheimer’s disease. Neural Plast. 2017, 1–12.

Publication types

MeSH terms

LinkOut - more resources